CON: Therapy for a patient with platinumresistant/refractory ovarian cancer should not be selected based on results of an in vitro extreme drug sensitivity/resistance assay

Academic Article

Digital Object Identifier (doi)

Author List

  • Farley J; Birrer MJ
  • Start Page

  • 57
  • End Page

  • 61
  • Volume

  • 4
  • Issue

  • 2